• market

  PRIVATE

• industry

  Biotechnology

• website

  flindrtx.com

Flindr develops a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer using their ImmunoGram Drug Discovery Engine, which enables them to discover novel targets in both cancer cells and immune cells.